Product: Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg,  6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Reason for recall: Failed Impurities/Degradation Specifications: out of specification impurity test results.
Recall initiated: 20140617
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated